ResMed Inc. (ASX: RMD) Share Price and News
Price
$38.34
Movement
0.64 (+1.7%)
As at 7 Nov 2:51pm (20 mins delayed)
52 Week Range
$32.04 - $45.25
1 Year Return
+3.62%
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
$38.34
Day Change
0.64 (+1.7%)
52 Week Range
$32.04 - $45.25
Yesterday's Close
$37.70
Today's Open
$38.13
Days Range
$37.94 - $38.48
Volume
3,029,728
Avg. Volume (1 month)
1,270,937
Turnover
$116,059,082
As at 7 Nov 2:51pm
ResMed Inc. (ASX: RMD)
Latest News
Share Fallers
This ASX 200 stock just dropped 20%. One expert just bought it
How to invest
Why I'd buy dirt-cheap ASX shares now and aim to hold them for a decade
Dividend Investing
Should I snap up ResMed shares in time for the next dividend?
Dividend Investing
4 ASX All Ords shares with ex-dividend dates next week
Healthcare Shares
Why has the Resmed share price crashed 19% in a week?
Broker Notes
Leading brokers name 3 ASX shares to buy today
Share Fallers
Why Lake Resources, Mesoblast, New Hope, and ResMed shares are falling today
Healthcare Shares
Why is the ResMed share price sinking again on Monday?
Share Market News
5 things to watch on the ASX 200 on Monday
Broker Notes
Top brokers name 3 ASX shares to buy next week
Share Fallers
Why Block, Flight Centre, Mesoblast, and ResMed shares are dropping
Earnings Results
ResMed share price crashes 10% on FY23 earnings miss
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.